CN-121987960-A - Magnetic therapy rod capable of generating static magnetic field for killing bacteria, tumor cells and viruses

Abstract

The invention discloses a magnetic therapy rod capable of generating static magnetic fields for killing bacteria, tumor cells and viruses, which comprises a shell and a magnetic therapy rod body, wherein a containing cavity is arranged in the shell, the magnetic therapy rod body is positioned in the containing cavity, the magnetic therapy rod body is formed by connecting a plurality of magnetic rods end to end, the magnetic poles of the magnetic rods are alternately arranged, the magnetic rods comprise the following raw materials, by weight, 97% -98.4% of strontium iron oxide, 0.20% -0.50% of aluminum oxide, 0.20% -0.50% of silicon dioxide, 0.04% -0.07% of phosphorus pentoxide, 0.04% -0.5% of sulfur oxide, 0.3% -0.7% of calcium oxide, 0.03% -0.06% of titanium oxide, 0.5% -0.70% of manganese oxide and 0.04% -0.06% of nickel oxide, and the magnetic therapy rod capable of generating the static magnetic fields for killing bacteria, tumor cells and viruses can generate the static magnetic fields, and the static magnetic fields are utilized to kill the bacteria, the tumor cells and the viruses, so that the effective treatment of cervical cancer, vaginitis and HPV is realized.

Inventors

• HUANG MINHUA
• GAO CHUNFANG
• Gao Jianglian
• LV ZHONGHUA
• ZHANG HEWEI
• ZHANG PANTAO
• LV ZHIWEI
• HUANG MINGGANG

Assignees

• 奥亿康医疗科技无锡有限公司

Dates

Publication Date

20260508

Application Date

20251223

Claims (9)

1. 1. The magnetic therapy rod is characterized by comprising a shell and a magnetic therapy rod body, wherein a containing cavity is formed in the shell, the magnetic therapy rod body is positioned in the containing cavity, the magnetic therapy rod body is formed by connecting a plurality of magnetic rods end to end, magnetic poles of the magnetic rods are alternately arranged in different poles, the magnetic rods comprise a main material, a first auxiliary material and a second auxiliary material, the main material comprises strontium iron oxide, the first auxiliary material comprises aluminum oxide, silicon dioxide and phosphorus pentoxide, and the second auxiliary material comprises sulfur oxide, calcium oxide, titanium oxide, manganese oxide and nickel oxide; the magnetic rod comprises the following raw materials, by weight, 97% -98.4% of strontium iron oxide, 0.20% -0.50% of aluminum oxide, 0.20% -0.50% of silicon dioxide, 0.04% -0.07% of phosphorus pentoxide, 0.04% -0.5% of sulfur oxide, 0.3% -0.7% of calcium oxide, 0.03% -0.06% of titanium oxide, 0.5% -0.70% of manganese oxide and 0.04% -0.06% of nickel oxide.
2. 2. The magnetic therapy rod capable of generating a static magnetic field for killing bacteria, tumor cells and viruses according to claim 1, wherein the magnetic rod comprises a rod body A and a rod body B, the magnetic poles of the rod body A are alternately arranged along the axial direction, and the magnetic poles of the rod body B are alternately arranged along the radial direction.
3. 3. The magnetotherapeutic rod capable of generating a static magnetic field for killing bacteria, tumor cells and viruses according to claim 2, wherein a mounting hole is formed at one end of the housing, limiting plates are arranged at two sides of the mounting hole, and the two limiting plates are integrally formed at two sides of the housing respectively.
4. 4. A magnetotherapeutic rod capable of generating a static magnetic field for killing bacteria, tumor cells, viruses according to claim 3, wherein said mounting hole is provided with a stopper.
5. 5. A magnetotherapeutic rod capable of generating a static magnetic field for killing bacteria, tumor cells and viruses according to claim 3, wherein the end of the outer shell far from the limiting plate is hemispherical.
6. 6. A magnetotherapeutic rod capable of generating a static magnetic field for killing bacteria, tumor cells, viruses according to claim 3, wherein the housing and the limiting plate are both made of medical ABS plastic.
7. 7. A magnetotherapeutic rod capable of generating a static magnetic field for killing bacteria, tumor cells, viruses according to claim 1, wherein the length of the housing is 92mm, the diameter of the housing is 15mm, and the thickness of the housing is 1mm.
8. 8. A magnetic therapy rod capable of generating a static magnetic field for killing bacteria, tumor cells and viruses according to claim 7, wherein the magnetic therapy rod body is formed by connecting two magnetic rods end to end, the length of the magnetic rod is 30mm, and the diameter of the magnetic therapy rod body is 13mm.
9. 9. The magnetic therapy rod capable of generating a static magnetic field for killing bacteria, tumor cells and viruses according to claim 8, wherein the magnetic field strength of the magnetic rod is 10-80mT, and the magnetic field strength of the magnetic therapy rod body is 40-110mT.

Description

Magnetic therapy rod capable of generating static magnetic field for killing bacteria, tumor cells and viruses Technical Field The invention relates to a magnetic therapy rod technology, in particular to a magnetic therapy rod capable of generating a static magnetic field for killing bacteria, tumor cells and viruses. Background The static magnetic field (STATIC MAGNETIC FIELD, SMF) refers to a magnetic field whose strength and direction do not change over time. SMF can inhibit proliferation of tumor cells by affecting cell calcium signal, oxidative stress and expression or activity of key cycle regulatory protein, and promote apoptosis of tumor cells by affecting physical properties of cytoskeleton and cell membrane lipid bilayer or conformation, aggregation state and signal transduction of membrane protein. In cancer treatment, static magnetic fields exhibit synergistic effects when used in combination with conventional therapies. The research shows that the composite magnetic field composed of the static magnetic field and the 50Hz very low frequency magnetic field has an anti-tumor effect on nephroblastoma and neuroblastoma cell lines (such as G401, CHLA255 and SK-N-SH), the combined use of the static magnetic field and the doxorubicin can remarkably inhibit the growth of liver cancer cell lines Hepa1-6 and remarkably enhance the inhibition of doxorubicin-induced human breast cancer MCF-7 cell growth and apoptosis, and the research published in 2025 shows that SMF has a definite cytotoxicity effect on triple negative breast cancer cells, can reduce the survival rate of the cancer cells to 58.14%, and brings new hope for patients. In the field of antibacterial application, research shows that the static magnetic field generated by the neodymium-iron-boron permanent magnet can directly influence the survival rate of escherichia coli, and the bacterial colony forming units are obviously reduced along with the extension of the exposure time and the increase of the magnetic field intensity. In recent years, with the development of technical means and systemization of research, a static magnetic field provides a new intervention means for various diseases due to the characteristics of non-invasiveness, deep penetrability and drug side effect avoidance, and simultaneously, SMF does not need an external power supply, has no electrothermal stimulation to tissues, has the advantages of small volume, convenient long-term local application and the like, has increasingly remarkable application value in the medical field, has been explored from laboratories to preclinical research in disease treatment, and has broad prospects. Cervical cancer is the fourth most common malignancy in women worldwide, severely threatening the health of women. The incidence rate of the cervical cancer is 3 rd in Chinese 15-44 year old women, and more than 10 ten thousand new cervical cancer cases occur in China each year, which is the second most cause of cancer death in women of the age group. Persistent infection with high-risk human papillomaviruses (Human Papillomavirus, HPV) is a major cause of pre-cervical lesions and cervical cancers, with which about 99% of cases are associated, in particular HPV16 and HPV-18. Persistent HPV infection induces oncogene expression and suppresses the function of oncogene, resulting in excessive proliferation of cervical cells and genomic instability, and evades immune system monitoring through various mechanisms, eventually developing into cervical cancer. Despite the existing various treatments such as surgery, radiotherapy and chemotherapy, patients with advanced cervical cancer still face risks of poor prognosis, recurrence and metastasis. In view of the above challenges, it is particularly important to develop novel safe and efficient prevention and treatment techniques for prevention and treatment of HPV infection. And vaginitis is one of the most common gynecological inflammations of women, and has various causes and high recurrence rate, thereby widely affecting reproductive health and quality of life. Vaginitis caused by bacterial infection is more common, not only causes visual puzzles such as itching, burning pain, peculiar smell and the like, but also can ascend along the genital tract if not treated normally, induce pelvic inflammatory disease and oviduct adhesion, and obviously increase the risks of infertility, ectopic pregnancy and chronic pelvic pain. Meanwhile, the long-term persistent vaginitis can also change the pH of the vaginal microenvironment, promote the persistent infection of high-risk HPV, indirectly increase the probability of cervical lesions and form an inflammation-infection-tumor event chain. In addition, bacterial vaginitis is easy to repeatedly attack along with the increasing problem of drug resistance, and the treatment difficulty rises year by year. Therefore, development of hormone-free and trauma-free therapeutic means capable of physically sterilizing or inhi